Ebola vaccine regimen generates strong immune response in children and adults in a clinical trial in Sierra Leone
Results support the use of Johnson & Johnson’s vaccine regimen for Ebola virus disease LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE Johnson & Johnson’s two-dose Ebola vaccine regimen… read more.